Redeye believes the data is solid and in line with previous readouts.
Redeye updates its valuation of Verve, which within two days announced two acquisitions that complem...
After announcing the proposed rights issue, we update our Base Case, including the number of shares.
Redeye comments on the directed share issue in which Sivers Semiconductors raised SEK95m before tran...
Atria announced today its TOGETHER 2030 strategy for 2025-30 with refined financial targets.
Q-linea proposes that a SEK 322m rights issue be secured at 85.
Första halvåret visade högre intäkter än föregående år, och tidiga beställningar inför tredje kvarta...
Redeye is positive on Senzime’s recent news flow, with contracts from important US hospitals.
Redeye comments on Verve's announced acquisition. The company is acquiring Acardo Group for EUR24.
With the rapidly occurring energy transition, significant investments have been made in the grid and...
Redeye is not surprised by the high subscription rate, considering the share has traded above the st...
Redeye comments on the announcement that CEO Pål Ryfors will step down of his own volition, with cur...
Redeye is pleased with TO13’s preliminary subscription rate of 91%.
Redeye is surprised by the low 69% acceptance rate from Integrum’s shareholders on the SEK44 bid by ...
Grangex nya DFS för Sydvaranger ökar visibiliteten och pekar på ytterligare värden.
EU-kommittén har röstat för ett godkännande av XP Chemistries kapsaicin som fodertillsats för alla d...
Redeye initiates coverage of Fractal Gaming Group, a Swedish premium gaming hardware brand best know...
Redeye comments on Cinclus’ announcement that the first patient has been screened in its pivotal Pha...
Redeye briefly comments on Guard announcing that the data collection for the phase IIb study POINTER...
Yesterday, Scibase announced that Ribbskottet AB and Life Science Investment Fund (LSIF), have each ...
